Tumour necrosis factor-alpha polymorphism increases the risk for nonvariceal upper gastrointestinal bleeding in patients taking proton pump inhibitors

Podobne knjige/članki

• Why do mortality rates for nonvariceal upper gastrointestinal bleeding differ around the world? A systematic review of cohort studies
  od: Jairath, Vipul, et al.
  Izdano: (2012)
• Predictors of early rebleeding after endoscopic therapy in patients with nonvariceal upper gastrointestinal bleeding secondary to high-risk lesions
  od: Maggio, Davide, et al.
  Izdano: (2013)
• Adherence to guidelines: A national audit of the management of acute upper gastrointestinal bleeding. The REASON registry
  od: Lu, Yidan, et al.
  Izdano: (2014)
• Prediction and prevention of upper gastrointestinal bleeding after cardiac surgery: A case control study
  od: Bhat, Mamatha, et al.
  Izdano: (2012)
• A 77-year-old man with nonvariceal upper gastrointestinal bleeding
  od: Fortinsky, Kyle J., et al.
  Izdano: (2014)